227 related articles for article (PubMed ID: 22478875)
1. Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.
Warner T; Nishi C; Checkowski R; Hall KW
Can J Hosp Pharm; 2009 Mar; 62(2):100-11. PubMed ID: 22478875
[TBL] [Abstract][Full Text] [Related]
2. Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.
Warner T; Nishi C; Checkowski R; Hall KW
Can J Hosp Pharm; 2009 May; 62(3):192-203. PubMed ID: 22478890
[TBL] [Abstract][Full Text] [Related]
3. Survey of sterile product compounding practices in Canadian hospital pharmacies.
Fitch DP; Hall KW
Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
[TBL] [Abstract][Full Text] [Related]
4. Practices of pharmacies that compound extemporaneous formulations.
Treadway AK; Craddock D; Leff R
Am J Health Syst Pharm; 2007 Jul; 64(13):1403-9. PubMed ID: 17592006
[TBL] [Abstract][Full Text] [Related]
5. Sterile Compounding Pharmacies: States That Do and Do Not Require Compliance With USP <797> Versus FDA 483s.
Wilson M
Ther Innov Regul Sci; 2016 May; 50(3):279-303. PubMed ID: 30227076
[TBL] [Abstract][Full Text] [Related]
6. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
Crawford SY; Narducci WA; Augustine SC
Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
[TBL] [Abstract][Full Text] [Related]
7. Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2.
Allen LV; Okeke CC
Int J Pharm Compd; 2007; 11(4):313-23. PubMed ID: 23974791
[TBL] [Abstract][Full Text] [Related]
8. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 4: considerations in selection and use of disinfectants and antiseptics.
Allen LV; Okeke CC
Int J Pharm Compd; 2007; 11(6):492-9. PubMed ID: 23994811
[TBL] [Abstract][Full Text] [Related]
9. Impact of United States Pharmacopeia chapter 797: results of a national survey.
Candy TA; Schneider PJ; Pedersen CA
Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
[TBL] [Abstract][Full Text] [Related]
10. National survey of quality assurance activities for pharmacy-compounded sterile preparations.
Morris AM; Schneider PJ; Pedersen CA; Mirtallo JM
Am J Health Syst Pharm; 2003 Dec; 60(24):2567-76. PubMed ID: 14735774
[TBL] [Abstract][Full Text] [Related]
11. USP <800>: Key Considerations and Changes for Health Systems.
Sahadeo P; Weber RJ
Hosp Pharm; 2015 Nov; 50(10):941-949. PubMed ID: 27729683
[TBL] [Abstract][Full Text] [Related]
12. Mayo Clinic approaches to meet United States Pharmacopeia <797> requirements for facility design and environmental controls of nuclear pharmacy.
Hung JC; Anderson MM
J Nucl Med; 2009 Jan; 50(1):156-64. PubMed ID: 19091891
[TBL] [Abstract][Full Text] [Related]
13. Considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 5: verification of accuracy, sterility, and sterilization of compounded preparations.
Allen LV; Okeke CC
Int J Pharm Compd; 2008; 12(1):54-60. PubMed ID: 23969573
[TBL] [Abstract][Full Text] [Related]
14. An overview of United States pharmacopeia chapter 795 and american society of health-system pharmacists guidelines for nonsterile compounding.
McElhiney LF
Int J Pharm Compd; 2009; 13(6):525-30. PubMed ID: 23965326
[TBL] [Abstract][Full Text] [Related]
15. Basics of compounding for the implementation of United States pharmaceopeia chapter 797 pharmaceutical compounding-sterile preparations, part 1.
Allen LV; Okeke C
Int J Pharm Compd; 2007; 11(3):230-6. PubMed ID: 23996026
[TBL] [Abstract][Full Text] [Related]
16. Leveraging a multidisciplinary oversight committee to ensure USP <797> and <800> compliance at a Veterans Affairs health system.
Wrzesniewski CE; Park HK
Am J Health Syst Pharm; 2022 Feb; 79(4):276-282. PubMed ID: 34724546
[TBL] [Abstract][Full Text] [Related]
17. [Validation of aseptic technique of parenteral nutrition compounding in a pharmacy service according to USP Chapter 797].
Romero Jiménez RM; Pernía López MS; Sánchez Fresneda MN; Sanjurjo Sáez M
Nutr Hosp; 2013; 28(5):1494-7. PubMed ID: 24160206
[TBL] [Abstract][Full Text] [Related]
18. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: personnel training, cleansing, and garbing.
Okeke CC; Allen LV
Int J Pharm Compd; 2009; 11(5):420-6. PubMed ID: 23966526
[TBL] [Abstract][Full Text] [Related]
19. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities--1995.
Santell JP; Kamalich RF
Am J Health Syst Pharm; 1996 Nov; 53(21):2591-605. PubMed ID: 8913388
[TBL] [Abstract][Full Text] [Related]
20. Pharmacy compounding of high-risk level products and patient safety.
Mullarkey T
Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
